FindMyRecallSubscribe
Class I: serious health riskTerminated

Ferring Pharmaceuticals Desmopressin Acetate Nasal Spray 10 mcg/0 Recall

Desmopressin Acetate Nasal Spray 10 mcg/0

Ferring Pharmaceuticals Inc · Parsippany, NJ

Risk level
Class I
Reported by FDA
Aug 26, 2020
Recall ID
D-1505-2020
Check your lot numberHow we source this data

Summary

Ferring Pharmaceuticals recalled Desmopressin Acetate Nasal Spray 10 mcg/0 starting Jul 21, 2020. The FDA classified it as Class I (serious health risk) and published enforcement report D-1505-2020 on Aug 26, 2020. Reason: Superpotent Drug. Status: Terminated.

Why it was recalled

Superpotent Drug

Product description

Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05

Lot numbers, UPCs & expiration codes

Lot #: N14695P, N14695S, exp. date 08 2020; N15627G , exp. date 10 2020 N15627GA, exp. date 10 2020 P10422A, exp. date 01 2021 P10422AA, exp. date 01 2021 P10430G, exp. date 03 2021 P11319M, exp. date 01 2021 P12969H, exp. date 05 2021 P12969IR, exp. date 05 2021 P13216G, exp. date 05 2021 P13216P, exp. date 05 2021 R11842A, exp. date 03 2022 R11842S, exp. date 03 2022 R12630A, exp. date 05 2022 R13071H, exp. date 04 2022

Where it was sold

Nationwide within the United States.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1505-2020
Classification
Class I
Status
Terminated
Recall initiated
Jul 21, 2020
FDA report date
Aug 26, 2020
Quantity
184,325 nasal sprays
Recall type
Voluntary: Firm initiated
Recalling firm
Ferring Pharmaceuticals Inc

Original FDA data

Every field from FDA enforcement report D-1505-2020, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Terminated
Country
United States
Event ID
86066
Address
100 Interpace Pkwy
Code information
Lot #: N14695P, N14695S, exp. date 08 2020; N15627G , exp. date 10 2020 N15627GA, exp. date 10 2020 P10422A, exp. date 01 2021 P10422AA, exp. date 01 2021 P10430G, exp. date 03 2021 P11319M, exp. date 01 2021 P12969H, exp. date 05 2021 P12969IR, exp. date 05 2021 P13216G, exp. date 05 2021 P13216P, exp. date 05 2021 R11842A, exp. date 03 2022 R11842S, exp. date 03 2022 R12630A, exp. date 05 2022 R13071H, exp. date 04 2022
Postal code
07054-1149
Report date
Aug 26, 2020
Product type
Drugs
Recall number
D-1505-2020
Classification
Class I
Recalling firm
Ferring Pharmaceuticals Inc
Product quantity
184,325 nasal sprays
Termination date
Oct 13, 2023
Reason for recall
Superpotent Drug
Voluntary / mandated
Voluntary: Firm initiated
Product description
Desmopressin Acetate Nasal Spray 10 mcg/0.1 mL, 5mL glass vial with spray cap, Rx only, Manufactured for: AMRING PHARMACEUTICALS INC., Berwyn, PA 19312, NDC 69918-501-05
Distribution pattern
Nationwide within the United States.
Recall initiation date
Jul 21, 2020
Initial firm notification
Letter
Center classification date
Aug 17, 2020

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1505-2020, published Aug 26, 2020. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls